Canopy Growth Smith Falls Facility Medical Cannabis Farm

Canadian cannabis company Canopy Growth has gained European Union Good Manufacturing Practice (EU GMP)certification for its facility in Smiths Falls, Ontario. The certification is a key requirement for supplying medical cannabis products to European patients.

According to Canopy’s announcement on 13 October, the certificate was issued by the Tübingen Regional Council(Regierungspräsidium Tübingen), the medicines regulator for the German state of Baden-Württemberg.

What’s covered

The certification covers:

  • Softgel manufacturing
  • Primary packaging of softgels, oral liquids and dried cannabis flower

Canopy says Smiths Falls is now the only Canadian cannabis facility with EU GMP certification covering that combined range of activities, based on the EU’s EudraGMDP certificate records as of 9 October 2026.

Why EU GMP matters

EU GMP is the quality standard that medicines must meet to be supplied in Europe. It covers everything from production and packaging to record-keeping and quality control. For medical cannabis producers outside the EU, it’s essentially the ticket to European pharmacies.

Canopy says the certification supports its plans to supply patient-ready medical cannabis products to European markets, subject to each product’s and market’s requirements.

“This EU GMP certification adds a capability that sets us apart,” said Luc Mongeau, Chief Executive Officer of Canopy Growth. He said it “accelerates our strategy to capture more value across our supply chain.”

Germany, Poland and the UK

Canopy has named Germany, Poland and the UK as focus markets. The certification is one of several recent European moves:

  • Kincardine, Ontario: its second facility has had its EU GMP certification renewed
  • UK: Canopy has expanded its Canadian-grown Spectrum Therapeutics flower range into the UK
  • Germany: it appointed Sebastian Blöte as Country Manager for Germany on 28 September

Why it matters

Europe’s medical cannabis markets are growing, led by Germany. But supplying them takes pharmaceutical-grade standards, not just good cultivation. Bringing manufacturing, packaging and certification together at one site gives Canopy more control over quality and costs. For the UK, where patients rely mainly on imported products, more EU GMP-certified supply could widen choice for prescribers.

Image Credit: Sean Kilpatrick/Canadian Press

Leave a Reply

Designed with WordPress